Boehringer Inaugurates Biopharma Mfg. Facility in China
Boehringer Ingelheim recently inaugurated its commercial production site for biopharmaceuticals in Zhang Jiang Hi-tech Park of Shanghai, China. The site, with the first-phase investment of more than 70 million, is the first and only biopharmaceutical facility established by a leading multinational active biopharmaceutical manufacturer in China utilizing mammalian cell culture technology.
Start the conversation, or Read more at Contract Pharma Breaking News.